NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature? - Top-Institutions - MDSpire

NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature?

  • By

  • Amalia Gastaldelli

  • Philip N Newsome

  • February 19, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Metabolic Diseases
    • Translational Research

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Metabolic Research

  • #3

    University of California, San Diego (UCSD) Health
    University of California, San Diego (UCSD) Health

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolic Disorders
    • Clinical Research

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hepatology
    • Metabolic Syndrome
    • Clinical Trials

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Hepatology
    • Metabolic Research
    • Basic Science

Original Source(s)

NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature?

  • by Amalia Gastaldelli, Philip N Newsome

  • February 19, 2025

Related Content

Real-World Insights on Metabolic Dysfunction-Associated Steatohepatitis: Evaluating Clinical Impact, Disease Progression, and Non-Invasive Risk Assessment

Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis

Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin